Moreover, GILZ-mediated inhibition of NF-κB nuclear translocation diminishes Cyclooxygenase 2 (COX-2) expression in bone marrow mesenchymal stem cells (MSCs) that were implicated in the pathogenesis and progression of RA (Chen and Tuan, 2008). The gene discussed is NFKB1; the disease is rheumatoid arthritis.